Potent CYP3A4 inhibitors (itraconazole, ketoconazole) may cause a clinically signifi- cant rise in dutasteride levels. The manufacturers suggest reducing the dosing frequency if increased dutasteride adverse effects occur.
(8)
This site is intended for general information only. The information provided on this site does not constitute medical advice and should not be relied upon. You should not act or refrain from acting on any legal or medical matter based on the content of this site.